Search results
Results from the WOW.Com Content Network
Globus delivered an exceptional third quarter with sales of $626 million, growing 63% or $242 million. Non-GAAP EPS was a record $0.83, increasing 45% even with the 20% increase in diluted shares ...
Welcome to Globus Medical's second-quarter 2024 earnings call. [Operator instructions] I'll now turn the call over to Brian Kearns, senior vice president of business development and investor ...
GMED earnings call for the period ending March 31, 2019.
Stock name Symbol Country of origin Safe Bulkers Inc. SB: Greece: Salesforce.com: CRM: US Sally Beauty Holdings: SBH: US San Juan Basin Royalty Trust SJT
Stock name Symbol Country of origin The Gabelli Convertible and Income Securities Fund, Inc. GCV: US The Gabelli Convertible and Income Securities Fund, Inc. GCV.PRB: US The Gabelli Dividend & Income Trust GDV: US The Gabelli Dividend & Income Trust GDV.PRA: US The Gabelli Dividend & Income Trust GDV.PRD: US The Gabelli Equity Trust Inc. GAB: US
Stock name Symbol Country of origin A. O. Smith Corporation: AOS: US A10 Networks, Inc. ATEN: US AAC Holdings Inc. AAC: US AAR Corporation: AIR: US Aaron's Inc.
For premium support please call: 800-290-4726 more ways to reach us
Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders .